BNT3214

· BioNTech SE

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BNT3214, covering 2026-04-01 to 2026-04-01. Get the full timeline:

Most recent: Clinical Trial Update: Early-phase Trial to Assess the Safety and Preliminary Efficacy of BNT3214 in Adults With Advanced Solid Tumors [Phase 1, Phase 2]

See pricing